SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001698530-22-000094
Filing Date
2022-12-14
Accepted
2022-12-14 07:11:47
Documents
17
Period of Report
2022-12-12
Items
Item 1.02: Termination of a Material Definitive Agreement
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K xcur-20221212.htm   iXBRL 8-K 43089
2 EX-10.1 exhibit101-mutualterminati.htm EX-10.1 29068
3 EX-10.2 exhibit102-letteragreement.htm EX-10.2 17907
4 EX-99.1 exhibit991pressreleasedate.htm EX-99.1 10345
8 exicureimage1a10.gif GRAPHIC 2794
9 image_0a.jpg GRAPHIC 39084
  Complete submission text file 0001698530-22-000094.txt   312207

Data Files

Seq Description Document Type Size
5 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT xcur-20221212.xsd EX-101.SCH 1905
6 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT xcur-20221212_lab.xml EX-101.LAB 24831
7 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT xcur-20221212_pre.xml EX-101.PRE 13045
11 EXTRACTED XBRL INSTANCE DOCUMENT xcur-20221212_htm.xml XML 11364
Mailing Address 2430 N. HALSTED ST. CHICAGO IL 60614
Business Address 2430 N. HALSTED ST. CHICAGO IL 60614 847-673-1700
EXICURE, INC. (Filer) CIK: 0001698530 (see all company filings)

IRS No.: 815333008 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39011 | Film No.: 221461128
SIC: 2834 Pharmaceutical Preparations